As one of the pioneers in advertising technology for healthcare marketers, DeepIntent and its 220+ dedicated employees across four different countries have built a robust healthcare advertising platform that empowers marketers to plan, activate, and optimize their digital ad campaigns on a single platform.
The proceeds provide the business with additional working capital as the company continues to scale the platform and onboard new advertisers and agencies.
“DeepIntent has been leading the healthcare advertising industry with data-driven solutions and bespoke technology,” said Chris Paquette, Founder and CEO of DeepIntent. “From day one, our mission has been to improve patient outcomes through the artful use of advertising, data science, and real-world clinical data. This funding will enable us to continue to lead pharma into the future by innovating and marketing to the future that is, not the past that was.”
“DeepIntent is a long-established industry leader,” said Randy Mitzman. “We look forward to working with this experienced team as they accelerate their growth and continue to provide superior advertising solutions to their customers.”